Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells

Journal of Innate Immunity

Volumn 6, Issue 3, 2014, Pages 339-352

  Prüfer, Steve ^a   Weber, Michael ^a   Sasca, Daniel ^a   Teschner, Daniel ^a   Wölfel, Catherine ^a   Stein, Pamela ^a   Stassen, Michael ^a   Schild, Hansjörg ^a   Radsak, Markus P ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Innate inflammatory response; Monocytes; Polymorphonuclear neutrophils; Signal transduction; TREM 1

Indexed keywords

CALCIUM; CRYOPYRIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; CD11B ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; AUTACOID; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM1 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEUKEMIA CELL; MONOCYTE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; CALCIUM TRANSPORT; CELL ACTIVATION; FLOW CYTOMETRY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MIDDLE AGED; MYELOID LEUKEMIA CELL LINE; UPREGULATION; WESTERN BLOTTING; ACUTE MYELOBLASTIC LEUKEMIA; ANTIBODY SPECIFICITY; CALCIUM SIGNALING; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE;

CALCIUM SIGNALING; CELL LINE, TUMOR; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LEUKEMIA, MYELOID, ACUTE; MEMBRANE GLYCOPROTEINS; MONOCYTES; NEUTROPHILS; ORGAN SPECIFICITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTORS;

EID: 84897470454     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000355892     Document Type: Article

References (41)

1. Radaev S, Kattah M, Rostro B, Colonna M, Sun PD: Crystal structure of the human myeloid cell activating receptor TREM-1. Structure 2003; 11: 1527-1535.
2. Kelker MS, Debler EW, Wilson IA: Crystal structure of mouse triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.76 Å. J Mol Biol 2004; 344: 1175-1181.
3. Bouchon A, Dietrich J, Colonna M: Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164: 4991-4995.
4. Ford JW, McVicar DW: TREM and TREMlike receptors in inflammation and disease. Curr Opin Immunol 2009; 21: 38-46.
5. Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103-1107.
6. Gibot S, Massin F, Marcou M, Taylor V, Stidwill R, Wilson P, et al: TREM-1 promotes survival during septic shock in mice. Eur J Immunol 2007; 37: 456-466.
7. Colonna M: TREMs in the immune system and beyond. Nat Rev Immunol 2003; 3: 445-453.
8. Klesney-Tait J, Keck K, Li X, Gilfillan S, Otero K, Baruah S, et al: Transepithelial migration of neutrophils into the lung requires TREM- 1. J Clin Invest 2013; 123: 138-149.
9. Sharif O, Knapp S: From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008; 213: 701-713.
10. Haselmayer P, Grosse-Hovest L, Landenberg von P, Schild H, Radsak MP: TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007; 110: 1029-1035.
11. Mezayen El R, Gazzar El M, Seeds MC, Mc- Call CE, Dreskin SC, Nicolls MR: Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 2007; 111: 36-44.
12. Gibot S, Buonsanti C, Massin F, Romano M, Kolopp-Sarda M-N, Benigni F, et al: Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 2006; 74: 2823-2830.
13. Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, et al: Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol 2012; 188: 5585-5592.
14. Radsak MP, Salih HR, Rammensee H-G, Schild H: Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 2004; 172: 4956-4963.
15. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, et al: A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 2003; 170: 3812-3818.
16. Tessarz AS, Cerwenka A: The TREM-1/ DAP12 pathway. Immunol Lett 2008; 116: 111-116.
17. Netea MG, Azam T, Ferwerda G, Girardin SE, Kim S-H, Dinarello CA: Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHTLRR (NLR) pattern recognition receptors. J Leukoc Biol 2006; 80: 1454-1461.
18. Gibot S, Kolopp-Sarda M-N, Béné MC, Bollaert P-E, Lozniewski A, Mory F, et al: A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004; 200: 1419-1426.
19. Haselmayer P, Daniel M, Tertilt C, Salih HR, Stassen M, Schild H, et al: Signaling pathways of the TREM-1- and TLR4-mediated neutrophil oxidative burst. J Innate Immun 2009; 1: 582-591.
20. Fortin CF, Lesur O, Fulop T: Effects of TREM- 1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol 2007; 19: 41-50.
21. Tessarz AS, Weiler S, Zanzinger K, Angelisová P, Horejsí V, Cerwenka A: Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. J Immunol 2007; 178: 1991-1999.
22. Gomez-Pina V, Martinez E, Fernandez-Ruiz I, del Fresno C, Soares-Schanoski A, Jurado T, et al: Role of MMPs in orchestrating inflammatory response in human monocytes via a TREM-1-PI3K-NF- B pathway. J Leukoc Biol 2012; 91: 933-945.
23. Fortin CF, Lesur O, Fulop T: Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. FEBS Lett 2007; 581: 1173-1178.
24. Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin L-L: Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol 2008; 180: 3520-3534.
25. Ormsby T, Schlecker E, Ferdin J, Tessarz AS, Angelisová P, Köprülü AD, et al: Btk is a positive regulator in the TREM-1/DAP12 signaling pathway. Blood 2011; 118: 936-945.
26. Radsak MP, Taube C, Haselmayer P, Tenzer S, Salih HR, Wiewrodt R, et al: Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007; 2007: 52040.
27. Quentmeier H, Duschl A, Hu ZB, Schnarr B, Zaborski M, Drexler HG: MUTZ-3, a monocytic model cell line for interleukin-4 and lipopolysaccharide studies. Immunology 1996; 89: 606-612.
28. Quentmeier H, Zaborski M, Drexler HG: The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. Leuk Res 1997; 21: 343-350.
29. Radsak MP, Hilf N, Singh-Jasuja H, Braedel S, Brossart P, Rammensee H-G, et al: The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions. Blood 2003; 101: 2810-2815.
30. Gingras M-C, Lapillonne H, Margolin JF: TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol 2002; 38: 817-824.
31. Gómez-Piña V, Soares-Schanoski A, Rodríguez- Rojas A, del Fresno C, García F, Vallejo- Cremades MT, et al: Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide- stimulated human monocytes. J Immunol 2007; 179: 4065-4073.
32. Santegoets SJAM, Masterson AJ, van der Sluis PC, Lougheed SM, Fluitsma DM, van den Eertwegh AJM, et al: A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor. J Leukoc Biol 2006; 80: 1337-1344.
33. Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T: Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 2004; 173: 7131-7134.
34. Masterson AJ, Sombroek CC, de Gruijl TD, Graus YMF, van der Vliet HJJ, Lougheed SM, et al: MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 2002; 100: 701-703.
35. Ciraci E, Barisani D, Parafioriti A, Formisano G, Arancia G, Bottazzo G, et al: CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts. Exp Hematol 2007; 35: 967-977.
36. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, et al: The proteinkinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727-736.
37. Burgering BMT, Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599-602.
38. Rane MJ: p38 Kinase-dependent MAPKAPK- 2 activation functions as 3-phosphoinositidedependent kinase-2 for Akt in human neutrophils. J Biol Chem 2000; 276: 3517-3523.
39. Heit B, Tavener S, Raharjo E, Kubes P: An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J Cell Biol 2002; 159: 91-102.
40. Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, Miller BJ, et al: PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat Immunol 2008; 9: 743-752.
41. Olieslagers S, Pardali E, Tchaikovski V, Dijke ten P, Waltenberger J: TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus. Cardiovasc Res 2011; 91: 510-518.